<page><title>Coffin-Lowry syndrome</title><url>https://medlineplus.gov/genetics/condition/coffin-lowry-syndrome</url><content>Coffin-Lowry syndrome
To use the sharing features on this page, please enable JavaScript.
Description
Coffin-Lowry syndrome is a condition that affects many parts of the body. The signs and symptoms are usually more severe in males than in females, although the features of this disorder range from very mild to severe in affected women.
Males with Coffin-Lowry syndrome typically have severe to profound intellectual disability and delayed development. Affected women may be cognitively normal, or they may have intellectual disability ranging from mild to profound.  Beginning in childhood or adolescence, some people with this condition experience brief episodes of collapse when excited or startled by a loud noise. These attacks are called stimulus-induced drop episodes (SIDEs).
Most affected males and some affected females have
distinctive facial features
including a prominent forehead, widely spaced and downward-slanting eyes, a short nose with a wide tip, and a wide mouth with full lips. These features become more pronounced with age. Soft hands with
short, tapered fingers
are also characteristic of Coffin-Lowry syndrome. Additional features of this condition include short stature, an unusually small head (
microcephaly
), progressive abnormal curvature of the spine (
kyphoscoliosis
), and other skeletal abnormalities.
Frequency
The incidence of this condition is uncertain, but researchers estimate that the disorder affects 1 in 40,000 to 50,000 people.
Causes
Mutations in the
RPS6KA3
gene cause Coffin-Lowry syndrome. This gene provides instructions for making a protein that is involved in signaling within cells. Researchers believe that this protein helps control the activity of other genes and plays an important role in the brain. The protein is involved in cell signaling pathways that are required for learning, the formation of long-term memories, and the survival of nerve cells. Gene mutations result in the production of little or no RPS6KA3 protein, but it is unclear how a lack of this protein causes the signs and symptoms of Coffin-Lowry syndrome.
Some people with the features of Coffin-Lowry syndrome do not have identified mutations in the
RPS6KA3
gene. In these cases, the cause of the condition is unknown.
Learn more about the gene associated with Coffin-Lowry syndrome
RPS6KA3
Inheritance
This condition is inherited in an
X-linked dominant pattern
. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two
sex chromosomes
. The inheritance is dominant if one copy of the altered gene in each cell is sufficient to cause the condition. In most cases, males (who have one X chromosome in each cell) experience more severe signs and symptoms of the disorder than females (who have two X chromosomes in each cell). A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.
Between 70 percent and 80 percent of people with Coffin-Lowry syndrome have no history of the condition in their families. These cases are caused by new mutations in the
RPS6KA3
gene.  The remaining 20 percent to 30 percent of affected individuals have other family members with Coffin-Lowry syndrome.
Other Names for This Condition
CLS
Mental retardation with osteocartilaginous abnormalities
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Coffin-Lowry syndrome
Genetic and Rare Diseases Information Center
Coffin-Lowry syndrome
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Clinical Trials
ClinicalTrials.gov
Catalog of Genes and Diseases from OMIM
COFFIN-LOWRY SYNDROME; CLS
Scientific Articles on PubMed
PubMed
References
Hanauer A, Young ID. Coffin-Lowry syndrome: clinical and molecular features. J
Med Genet. 2002 Oct;39(10):705-13. doi: 10.1136/jmg.39.10.705.
Citation on PubMed
or
Free article on PubMed Central
Herrera-Soto JA, Santiago-Cornier A, Segal LS, Ramirez N, Tamai J. The
musculoskeletal manifestations of the Coffin-Lowry syndrome. J Pediatr Orthop.
2007 Jan-Feb;27(1):85-9. doi: 10.1097/01.bpo.0000187994.94515.9d.
Citation on PubMed
Hunter AG. Coffin-Lowry syndrome: a 20-year follow-up and review of long-term
outcomes. Am J Med Genet. 2002 Sep 1;111(4):345-55. doi: 10.1002/ajmg.10574.
Citation on PubMed
Nishimoto HK, Ha K, Jones JR, Dwivedi A, Cho HM, Layman LC, Kim HG. The
historical Coffin-Lowry syndrome family revisited: identification of two novel
mutations of RPS6KA3 in three male patients. Am J Med Genet A. 2014
Sep;164A(9):2172-9. doi: 10.1002/ajmg.a.36488. Epub 2014 Jul 7.
Citation on PubMed
Rogers RC, Abidi FE. RPS6KA3-Related Intellectual Disability. 2002
Jul 16 [updated 2023 Mar 16]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA,
Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(R)
[Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available
from http://www.ncbi.nlm.nih.gov/books/NBK1346/
Citation on PubMed
Rojnueangnit K, Jones JR, Basehore MJ, Robin NH. Classic phenotype of
Coffin-Lowry syndrome in a female with stimulus-induced drop episodes and a
genotype with preserved N-terminal kinase domain. Am J Med Genet A. 2014
Feb;164A(2):516-21. doi: 10.1002/ajmg.a.36299. Epub 2013 Dec 5.
Citation on PubMed
Stephenson JB, Hoffman MC, Russell AJ, Falconer J, Beach RC, Tolmie JL,
McWilliam RC, Zuberi SM. The movement disorders of Coffin-Lowry syndrome. Brain
Dev. 2005 Mar;27(2):108-13. doi: 10.1016/j.braindev.2003.11.010.
Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>